Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis-Reference-Cited by-同舟云学术

Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis

Published:2013-07 Issue:4 Volume:12 Page:431-439
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Lazzarotto César,Ronsoni Marcelo Fernando,Fayad Leonardo,Nogueira Christiane Lourenço,Bazzo Maria Luiza,Narciso-Schiavon Janaína Luz,Schiavon Leonardo de Lucca,Dantas-Corrêa Esther Buzaglo

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference35 articles.

1. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis;Fernandez;Hepatology,2002

2. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis;Arvaniti;Gastroenterology,2010

3. Gut microflora in the pathogenesis of the complications of cirrhosis;Garcia-Tsao;Best Pract Res Clin Gastroenterol,2004

4. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis;Wasmuth;J Hepatol,2005

5. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome;Mookerjee;Hepatology,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxis and Treatment of Bacterial Infections in Cirrhosis;Current Hepatology Reports;2024-01-18

2. A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis;Hepatology Communications;2024-01

3. Diagnostic agreement of presepsin, procalcitonin, C-reactive protein and white blood cell count in patients with suspected sepsis;Acta Facultatis Medicae Naissensis;2024

4. Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus;Advances in Therapy;2023-02-20

5. Liver cirrhosis and immune dysfunction;International Immunology;2022-07-06